CAT No: R2227
CAS No: 141136-83-6
Synonyms/Alias: TRAP-6;141136-83-6;Thrombin Receptor Activator Peptide 6;L-Seryl-L-phenylalanyl-L-leucyl-L-leucyl-L-arginyl-L-asparagine;Ser-Phe-Leu-Leu-Arg-Asn;MFCD00238172;SFLLRN;(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-oxobutanoic acid;(2S,5S,8S,11S,14S,17S)-17-Amino-2-(2-amino-2-oxoethyl)-14-benzyl-5-(3-guanidinopropyl)-18-hydroxy-8,11-diisobutyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazaoctadecan-1-oic acid;PAR1 agonist;SFLLRN-OH;PAR-1 agonist peptide;TRAP 6;Thrombin Receptor (1-6);PAR-1 agonist peptide;Thrombin Receptor Activator Peptide 6;TRAP-6?;CHEMBL78392;SCHEMBL15929733;BDBM85086;DTXSID90431405;HAGOWCONESKMDW-FRSCJGFNSA-N;HY-P0078;AKOS024457641;CS-5508;Coagulation Factor II Receptor (1-6);NCGC00167239-01;AC-32572;AS-71526;DA-78586;C72622;Thrombin Receptor Activator Peptide 6, >95% (HPLC);L-Asparagine,l-seryl-L-phenylalanyl-L-Leucyl-L-leucyl-l-arginyl-;(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-phenylpropanamido]-4-methylpentanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanoic acid;(2S,5S,8S,11S,14S,17S)-17-Amino-2-(2-amino-2-oxoethyl)-14-benzyl-5-(3-guanidinopropyl)-18-hydroxy-8,11-diisobutyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazaoctadecan-1-oicacid;141136-83-6, TRAP 6, Thrombin Receptor Activator Peptide 6, PAR1 agonist, Thrombin Receptor (1-6), Coagulation Factor II Receptor (1-6);
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C34H56N10O9 |
M.W/Mr. | 748.9 |
Sequence | One Letter Code:SFLLRN Three Letter Code:H-Ser-Phe-Leu-Leu-Arg-Asn-OH |
InChI | InChI=1S/C34H56N10O9/c1-18(2)13-23(30(49)40-22(11-8-12-39-34(37)38)29(48)44-26(33(52)53)16-27(36)46)42-31(50)24(14-19(3)4)43-32(51)25(41-28(47)21(35)17-45)15-20-9-6-5-7-10-20/h5-7,9-10,18-19,21-26,45H,8,11-17,35H2,1-4H3,(H2,36,46)(H,40,49)(H,41,47)(H,42,50)(H,43,51)(H,44,48)(H,52,53)(H4,37,38,39)/t21-,22-,23-,24-,25-,26-/m0/s1 |
InChI Key | HAGOWCONESKMDW-FRSCJGFNSA-N |
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
Required fields are marked with *
×Required fields are marked with *
×If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com